» Articles » PMID: 32883256

Serum Macrophage Migration Inhibition Factor for Diagnosing Endometriosis and Its Severity: Case-control Study

Overview
Publisher Biomed Central
Date 2020 Sep 5
PMID 32883256
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endometriosis is a long-standing progressive disease that affects women of reproductive age. Macrophage migration inhibitory factor (MIF) is one of non-invasive blood biomarker that was detected in sera of endometriotic patients. The present study aimed to determine the accuracy of serum MIF in diagnosing endometriosis in women with infertility and chronic pelvic pain, and correlate its level to the stage of the disease.

Methods: Observational case-control study conducted at Fayoum University hospital from March 2016 till September 2018. Three hundred women candidate for diagnostic laparoscopy for either infertility or gynecologic chronic pelvic pain were included. The study group included patients with symptoms suggestive of endometriosis or chocolate cyst by ultrasound and proved by laparoscopy and histopathology. The control group included other causes of infertility or pelvic pain. All patients undergone either diagnostic or operative laparoscopy, and before laparoscopy blood sampling for quantitative measurement of macrophage migration inhibitory factor (MIF) protein in serum by ELISA technique.

Results: The level of serum MIF was significantly higher in endometriosis group compared to control group (1.75 ± 1.48 pg/ml and 0.51 ± 0.45 pg/ ml, respectively, P = < 0.001), with a progressive increase with advancing stage (stage I, 1.3 ± 1.03 pg/ml, stage II, 1.7 ± 1.57 pg/ml, stage III, 2.1 ± 1.19 pg/ml and in stage IV, 3.2 ± 2.6 pg/ml). Moreover, in patients presented with pain and infertile patients showed significantly higher levels of serum MIF (1.92 ± 1.13 vs 1.21 ± 1.17 and 1.82 ± 1.13 vs 1.32 ± 0.91 respectively with p-value < 0.001). ROC curve of serum MIF with a cut off value of 0.85 pg/ml or more achieves a sensitivity of 80.6%, specificity of 83.3%, positive predictive value of 82.9% and negative predictive value of 81.2%.

Conclusion: Serum MIF might be a promising marker not only for noninvasive diagnosis of endometriosis but as a target for detecting severity as well.

Citing Articles

Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives.

Chen S, Liu Y, Zhong Z, Wei C, Liu Y, Zhu X Front Immunol. 2023; 14:1134663.

PMID: 36865552 PMC: 9971222. DOI: 10.3389/fimmu.2023.1134663.


Inflammatory MicroRNAs and the Pathophysiology of Endometriosis and Atherosclerosis: Common Pathways and Future Directions Towards Elucidating the Relationship.

Azari Z, Aljubran F, Nothnick W Reprod Sci. 2022; 29(8):2089-2104.

PMID: 35476352 DOI: 10.1007/s43032-022-00955-6.


Pre- and Post-Interventional Changes in Physiological Profiles in a Patient Presenting With Opioid Withdrawal After Intrathecal Drug Delivery System Failure Related to Assumed Catheter Microfracture.

Ehsanian R, Koshkin E, Goins A, Montera M, Alles S Cureus. 2021; 13(5):e14835.

PMID: 34104585 PMC: 8173817. DOI: 10.7759/cureus.14835.

References
1.
Ozhan E, Kokcu A, Yanik K, Gunaydin M . Investigation of diagnostic potentials of nine different biomarkers in endometriosis. Eur J Obstet Gynecol Reprod Biol. 2014; 178:128-33. DOI: 10.1016/j.ejogrb.2014.04.037. View

2.
Sales K, Jabbour H . Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction. 2003; 126(5):559-67. PMC: 2695735. DOI: 10.1530/rep.0.1260559. View

3.
Veillat V, Carli C, Metz C, Al-Abed Y, Naccache P, Akoum A . Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways. J Clin Endocrinol Metab. 2010; 95(12):E403-12. DOI: 10.1210/jc.2010-0417. View

4.
. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997; 67(5):817-21. DOI: 10.1016/s0015-0282(97)81391-x. View

5.
Lagana A, Garzon S, Gotte M, Vigano P, Franchi M, Ghezzi F . The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights. Int J Mol Sci. 2019; 20(22). PMC: 6888544. DOI: 10.3390/ijms20225615. View